ID   HYEP_HUMAN              Reviewed;         455 AA.
AC   P07099; B2R8N0; Q5VTJ6; Q9NP75; Q9NPE7; Q9NQU6; Q9NQU7; Q9NQU8; Q9NQU9;
AC   Q9NQV0; Q9NQV1; Q9NQV2;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1988, sequence version 1.
DT   28-JUN-2023, entry version 215.
DE   RecName: Full=Epoxide hydrolase 1 {ECO:0000305};
DE            EC=3.3.2.9 {ECO:0000250|UniProtKB:P07687};
DE   AltName: Full=Epoxide hydratase;
DE   AltName: Full=Microsomal epoxide hydrolase;
DE            Short=mEH {ECO:0000305};
GN   Name=EPHX1 {ECO:0000312|HGNC:HGNC:3401}; Synonyms=EPHX, EPOX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 1-19.
RX   PubMed=2891713; DOI=10.1016/s0021-9258(19)57339-2;
RA   Skoda R.C., Demierre A., McBride O.W., Gonzalez F.J., Meyer U.A.;
RT   "Human microsomal xenobiotic epoxide hydrolase. Complementary DNA sequence,
RT   complementary DNA-directed expression in COS-1 cells, and chromosomal
RT   localization.";
RL   J. Biol. Chem. 263:1549-1554(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal liver;
RA   Wilson N.M., Omiecinski C.J.;
RT   "Nucleotide sequence of a human microsomal epoxide hydrolase cDNA clone.";
RL   Submitted (JUL-1988) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=3502697; DOI=10.1093/nar/15.17.7188;
RA   Jackson M.R., Craft J.A., Burchell B.;
RT   "Nucleotide and deduced amino acid sequence of human liver microsomal
RT   epoxide hydrolase.";
RL   Nucleic Acids Res. 15:7188-7188(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS HIS-113; ARG-139 AND ILE-396.
RC   TISSUE=Liver;
RX   PubMed=7516776; DOI=10.1093/hmg/3.3.421;
RA   Hassett C., Aicher L., Sidhu J.S., Omiecinski C.J.;
RT   "Human microsomal epoxide hydrolase: genetic polymorphism and functional
RT   expression in vitro of amino acid variants.";
RL   Hum. Mol. Genet. 3:421-428(1994).
RN   [5]
RP   ERRATUM OF PUBMED:7516776.
RA   Hassett C., Aicher L., Sidhu J.S., Omiecinski C.J.;
RL   Hum. Mol. Genet. 3:1214-1214(1994).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7835893; DOI=10.1006/geno.1994.1520;
RA   Hassett C., Robinson K.B., Beck N.B., Omiecinski C.J.;
RT   "The human microsomal epoxide hydrolase gene (EPHX1): complete nucleotide
RT   sequence and structural characterization.";
RL   Genomics 23:433-442(1994).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain cortex;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS THR-43; HIS-113; ARG-139;
RP   LEU-285; MET-408 AND GLN-452.
RG   NIEHS SNPs program;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin, Testis, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 9-327.
RC   TISSUE=Liver;
RA   Craft J.A., Jackson M.R., Burchell B.;
RT   "Partial nucleotide sequence of a cloned cDNA for human liver microsomal
RT   epoxide hydrolase.";
RL   Biochem. Soc. Trans. 15:708-709(1987).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-197; 242-310 AND 348-455, AND
RP   VARIANTS CYS-49; HIS-113; ARG-139; PRO-260 AND GLN-454.
RX   PubMed=11058921;
RX   DOI=10.1002/1098-1004(200011)16:5<450::aid-humu28>3.0.co;2-1;
RA   Belmahdi F., Chevalier D., Lo-Guidice J.-M., Allorge D., Cauffiez C.,
RA   Lafitte J.-J., Broly F.;
RT   "Identification of 6 new polymorphisms, g.11177G>A, g.14622C>T (R49C),
RT   g.17540T>C, g.17639T>C, g.30929T>C, g.31074G>A (R454Q), in the human
RT   microsomal epoxide hydrolase gene (EPHX1) in a French population.";
RL   Hum. Mutat. 16:450-450(2000).
RN   [13]
RP   POTENTIAL INVOLVEMENT IN HYPERCHOLANEMIA, AND TISSUE SPECIFICITY.
RX   PubMed=12878321; DOI=10.1016/s0925-4439(03)00085-1;
RA   Zhu Q.S., Xing W., Qian B., von Dippe P., Shneider B.L., Fox V.L., Levy D.;
RT   "Inhibition of human m-epoxide hydrolase gene expression in a case of
RT   hypercholanemia.";
RL   Biochim. Biophys. Acta 1638:208-216(2003).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=22798687; DOI=10.1194/jlr.m024448;
RA   Decker M., Adamska M., Cronin A., Di Giallonardo F., Burgener J.,
RA   Marowsky A., Falck J.R., Morisseau C., Hammock B.D., Gruzdev A.,
RA   Zeldin D.C., Arand M.;
RT   "EH3 (ABHD9): the first member of a new epoxide hydrolase family with high
RT   activity for fatty acid epoxides.";
RL   J. Lipid Res. 53:2038-2045(2012).
RN   [16]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=24958911; DOI=10.1194/jlr.m051284;
RA   Nithipatikom K., Endsley M.P., Pfeiffer A.W., Falck J.R., Campbell W.B.;
RT   "A novel activity of microsomal epoxide hydrolase: metabolism of the
RT   endocannabinoid 2-arachidonoylglycerol.";
RL   J. Lipid Res. 55:2093-2102(2014).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [19]
RP   VARIANTS HIS-113 AND ARG-139, AND DISEASE.
RX   PubMed=12173035; DOI=10.1038/sj.ejhg.5200849;
RA   Laasanen J., Romppanen E.-L., Hiltunen M., Helisalmi S., Mannermaa A.,
RA   Punnonen K., Heinonen S.;
RT   "Two exonic single nucleotide polymorphisms in the microsomal epoxide
RT   hydrolase gene are jointly associated with preeclampsia.";
RL   Eur. J. Hum. Genet. 10:569-573(2002).
RN   [20]
RP   VARIANT GLN-44.
RX   PubMed=15618730; DOI=10.2133/dmpk.18.150;
RA   Shiseki K., Itoda M., Saito Y., Nakajima Y., Maekawa K., Kimura H.,
RA   Goto Y., Saitoh O., Katoh M., Ohnuma T., Kawai M., Sugai K., Ohtsuki T.,
RA   Suzuki C., Minami N., Ozawa S., Sawada J.;
RT   "Five novel single nucleotide polymorphisms in the EPHX1 gene encoding
RT   microsomal epoxide hydrolase.";
RL   Drug Metab. Pharmacokinet. 18:150-153(2003).
RN   [21]
RP   CHARACTERIZATION OF VARIANTS HIS-113 AND ARG-139.
RX   PubMed=15535985; DOI=10.1016/j.cbi.2004.07.004;
RA   Hosagrahara V.P., Rettie A.E., Hassett C., Omiecinski C.J.;
RT   "Functional analysis of human microsomal epoxide hydrolase genetic
RT   variants.";
RL   Chem. Biol. Interact. 150:149-159(2004).
CC   -!- FUNCTION: Biotransformation enzyme that catalyzes the hydrolysis of
CC       arene and aliphatic epoxides to less reactive and more water soluble
CC       dihydrodiols by the trans addition of water (By similarity). Plays a
CC       role in the metabolism of endogenous lipids such as epoxide-containing
CC       fatty acids (PubMed:22798687). Metabolizes the abundant endocannabinoid
CC       2-arachidonoylglycerol (2-AG) to free arachidonic acid (AA) and
CC       glycerol (PubMed:24958911). {ECO:0000250|UniProtKB:P07687,
CC       ECO:0000269|PubMed:22798687, ECO:0000269|PubMed:24958911}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=cis-stilbene oxide + H2O = (1R,2R)-hydrobenzoin;
CC         Xref=Rhea:RHEA:23900, ChEBI:CHEBI:15377, ChEBI:CHEBI:50004,
CC         ChEBI:CHEBI:50014; EC=3.3.2.9;
CC         Evidence={ECO:0000269|PubMed:24958911};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:23901;
CC         Evidence={ECO:0000269|PubMed:24958911};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(4-methoxyphenyl)-N-methyl-N-[(3-methyloxetan-3-
CC         yl)methyl]methanamine + H2O = 2-{[(4-
CC         methoxybenzyl)(methyl)amino]methyl}-2-methylpropane-1,3-diol;
CC         Xref=Rhea:RHEA:55764, ChEBI:CHEBI:15377, ChEBI:CHEBI:139161,
CC         ChEBI:CHEBI:139164; EC=3.3.2.9;
CC         Evidence={ECO:0000250|UniProtKB:P07687};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=8,9-epoxy-(5Z,11Z,14Z)-eicosatrienoate + H2O = 8,9-dihydroxy-
CC         (5Z,11Z,14Z)-eicosatrienoate; Xref=Rhea:RHEA:44048,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:84025, ChEBI:CHEBI:84032;
CC         Evidence={ECO:0000269|PubMed:22798687};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44049;
CC         Evidence={ECO:0000269|PubMed:22798687};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=11,12-epoxy-(5Z,8Z,14Z)-eicosatrienoate + H2O = 11,12-
CC         dihydroxy-(5Z,8Z,14Z)-eicosatrienoate; Xref=Rhea:RHEA:44044,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:76625, ChEBI:CHEBI:84031;
CC         Evidence={ECO:0000269|PubMed:22798687};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44045;
CC         Evidence={ECO:0000269|PubMed:22798687};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycerol + H2O =
CC         (5Z,8Z,11Z,14Z)-eicosatetraenoate + glycerol + H(+);
CC         Xref=Rhea:RHEA:26132, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17754, ChEBI:CHEBI:32395, ChEBI:CHEBI:52392;
CC         Evidence={ECO:0000269|PubMed:24958911};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:26133;
CC         Evidence={ECO:0000269|PubMed:24958911};
CC   -!- ACTIVITY REGULATION: Inhibited by 10-hydroxystearamide and methoxy-
CC       arachidonyl fluorophosphate. {ECO:0000269|PubMed:24958911}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.8 uM for 8,9-EET {ECO:0000269|PubMed:22798687};
CC         KM=0.4 uM for 11,12-EET {ECO:0000269|PubMed:22798687};
CC         KM=0.9 uM for 14,15-EET {ECO:0000269|PubMed:22798687};
CC         KM=5.8 uM for leukotoxin {ECO:0000269|PubMed:22798687};
CC         Vmax=0.12 umol/min/mg enzyme with 8,9-EET as substrate
CC         {ECO:0000269|PubMed:22798687};
CC         Vmax=0.6 umol/min/mg enzyme with 11,12-EET as substrate
CC         {ECO:0000269|PubMed:22798687};
CC         Vmax=0.04 umol/min/mg enzyme with 14,15-EET as substrate
CC         {ECO:0000269|PubMed:22798687};
CC         Vmax=0.008 umol/min/mg enzyme with leukotoxin as substrate
CC         {ECO:0000269|PubMed:22798687};
CC   -!- INTERACTION:
CC       P07099; P23560-2: BDNF; NbExp=3; IntAct=EBI-6138796, EBI-12275524;
CC   -!- SUBCELLULAR LOCATION: Microsome membrane {ECO:0000269|PubMed:24958911};
CC       Single-pass type III membrane protein {ECO:0000255}. Endoplasmic
CC       reticulum membrane {ECO:0000250|UniProtKB:P07687}; Single-pass type III
CC       membrane protein {ECO:0000250|UniProtKB:P07687}.
CC   -!- TISSUE SPECIFICITY: Found in liver. {ECO:0000269|PubMed:12878321}.
CC   -!- DISEASE: Note=In some populations, the high activity haplotype
CC       tyr113/his139 is overrepresented among women suffering from pregnancy-
CC       induced hypertension (pre-eclampsia) when compared with healthy
CC       controls. {ECO:0000269|PubMed:12173035}.
CC   -!- DISEASE: Note=Variations in EPHX1 gene non-coding regions have been
CC       observed in a patient with hypercholanemia. The pathogenicity of these
CC       variants has not been confirmed. {ECO:0000269|PubMed:12878321}.
CC   -!- SIMILARITY: Belongs to the peptidase S33 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/ephx1/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J03518; AAA61305.1; -; mRNA.
DR   EMBL; X07936; CAA30759.1; -; mRNA.
DR   EMBL; Y00424; CAA68486.1; -; mRNA.
DR   EMBL; L25878; AAA52389.1; -; mRNA.
DR   EMBL; L25879; AAA52390.1; -; mRNA.
DR   EMBL; U06661; AAB60649.1; -; Genomic_DNA.
DR   EMBL; U06656; AAB60649.1; JOINED; Genomic_DNA.
DR   EMBL; U06657; AAB60649.1; JOINED; Genomic_DNA.
DR   EMBL; U06658; AAB60649.1; JOINED; Genomic_DNA.
DR   EMBL; U06659; AAB60649.1; JOINED; Genomic_DNA.
DR   EMBL; U06660; AAB60649.1; JOINED; Genomic_DNA.
DR   EMBL; AK313436; BAG36227.1; -; mRNA.
DR   EMBL; AY948961; AAX81410.1; -; Genomic_DNA.
DR   EMBL; AL591895; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC003567; AAH03567.1; -; mRNA.
DR   EMBL; BC008291; AAH08291.1; -; mRNA.
DR   EMBL; BC095430; AAH95430.1; -; mRNA.
DR   EMBL; M36374; AAA59580.1; -; mRNA.
DR   EMBL; AF253417; AAC41694.1; -; Genomic_DNA.
DR   EMBL; AF276626; AAF87726.1; -; Genomic_DNA.
DR   EMBL; AF276627; AAF87727.1; -; Genomic_DNA.
DR   EMBL; AF276628; AAF87728.1; -; Genomic_DNA.
DR   EMBL; AF276629; AAF87729.1; -; Genomic_DNA.
DR   EMBL; AF276630; AAF87730.1; -; Genomic_DNA.
DR   EMBL; AF276631; AAF87731.1; -; Genomic_DNA.
DR   EMBL; AF276632; AAF87732.1; -; Genomic_DNA.
DR   EMBL; AF276633; AAF87733.1; -; Genomic_DNA.
DR   EMBL; AF276634; AAF87734.1; -; Genomic_DNA.
DR   EMBL; AF276635; AAF87735.1; -; Genomic_DNA.
DR   EMBL; AF276636; AAF87736.1; -; Genomic_DNA.
DR   EMBL; AF276637; AAF87737.1; -; Genomic_DNA.
DR   EMBL; AF276638; AAF87738.1; -; Genomic_DNA.
DR   CCDS; CCDS1547.1; -.
DR   PIR; A29939; A29939.
DR   RefSeq; NP_000111.1; NM_000120.3.
DR   RefSeq; NP_001129490.1; NM_001136018.3.
DR   RefSeq; NP_001278092.1; NM_001291163.1.
DR   AlphaFoldDB; P07099; -.
DR   SMR; P07099; -.
DR   BioGRID; 108366; 138.
DR   IntAct; P07099; 22.
DR   MINT; P07099; -.
DR   STRING; 9606.ENSP00000480004; -.
DR   BindingDB; P07099; -.
DR   ChEMBL; CHEMBL1968; -.
DR   DrugBank; DB00808; Indapamide.
DR   DrugBank; DB00252; Phenytoin.
DR   DrugCentral; P07099; -.
DR   SwissLipids; SLP:000001117; -.
DR   ESTHER; human-EPHX1; Epoxide_hydrolase.
DR   MEROPS; S33.971; -.
DR   GlyGen; P07099; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P07099; -.
DR   PhosphoSitePlus; P07099; -.
DR   SwissPalm; P07099; -.
DR   BioMuta; EPHX1; -.
DR   DMDM; 123926; -.
DR   CPTAC; CPTAC-1613; -.
DR   CPTAC; CPTAC-359; -.
DR   CPTAC; CPTAC-360; -.
DR   EPD; P07099; -.
DR   jPOST; P07099; -.
DR   MassIVE; P07099; -.
DR   PaxDb; P07099; -.
DR   PeptideAtlas; P07099; -.
DR   ProteomicsDB; 51949; -.
DR   Antibodypedia; 34646; 496 antibodies from 29 providers.
DR   DNASU; 2052; -.
DR   Ensembl; ENST00000272167.10; ENSP00000272167.5; ENSG00000143819.13.
DR   Ensembl; ENST00000366837.5; ENSP00000355802.4; ENSG00000143819.13.
DR   Ensembl; ENST00000614058.4; ENSP00000480004.1; ENSG00000143819.13.
DR   GeneID; 2052; -.
DR   KEGG; hsa:2052; -.
DR   MANE-Select; ENST00000272167.10; ENSP00000272167.5; NM_001136018.4; NP_001129490.1.
DR   AGR; HGNC:3401; -.
DR   CTD; 2052; -.
DR   DisGeNET; 2052; -.
DR   GeneCards; EPHX1; -.
DR   HGNC; HGNC:3401; EPHX1.
DR   HPA; ENSG00000143819; Tissue enhanced (adrenal gland, liver).
DR   MalaCards; EPHX1; -.
DR   MIM; 132810; gene.
DR   neXtProt; NX_P07099; -.
DR   OpenTargets; ENSG00000143819; -.
DR   Orphanet; 238475; Familial hypercholanemia.
DR   PharmGKB; PA27829; -.
DR   VEuPathDB; HostDB:ENSG00000143819; -.
DR   eggNOG; KOG2565; Eukaryota.
DR   GeneTree; ENSGT00390000002210; -.
DR   HOGENOM; CLU_019414_3_0_1; -.
DR   InParanoid; P07099; -.
DR   OMA; LYIHKPF; -.
DR   OrthoDB; 5472392at2759; -.
DR   PhylomeDB; P07099; -.
DR   TreeFam; TF313813; -.
DR   BioCyc; MetaCyc:HS07112-MON; -.
DR   BRENDA; 3.3.2.9; 2681.
DR   PathwayCommons; P07099; -.
DR   Reactome; R-HSA-211945; Phase I - Functionalization of compounds.
DR   SABIO-RK; P07099; -.
DR   SignaLink; P07099; -.
DR   BioGRID-ORCS; 2052; 18 hits in 1161 CRISPR screens.
DR   ChiTaRS; EPHX1; human.
DR   GeneWiki; EPHX1; -.
DR   GenomeRNAi; 2052; -.
DR   Pharos; P07099; Tchem.
DR   PRO; PR:P07099; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P07099; protein.
DR   Bgee; ENSG00000143819; Expressed in right adrenal gland cortex and 184 other tissues.
DR   ExpressionAtlas; P07099; baseline and differential.
DR   Genevisible; P07099; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0033961; F:cis-stilbene-oxide hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0004301; F:epoxide hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0019369; P:arachidonic acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0019439; P:aromatic compound catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0097176; P:epoxide metabolic process; IDA:UniProtKB.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0009636; P:response to toxic substance; IEA:UniProtKB-KW.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   Gene3D; 3.40.50.1820; alpha/beta hydrolase; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR000073; AB_hydrolase_1.
DR   InterPro; IPR000639; Epox_hydrolase-like.
DR   InterPro; IPR016292; Epoxide_hydrolase.
DR   PANTHER; PTHR21661:SF78; EPOXIDE HYDROLASE 1; 1.
DR   PANTHER; PTHR21661; EPOXIDE HYDROLASE 1-RELATED; 1.
DR   Pfam; PF00561; Abhydrolase_1; 1.
DR   PIRSF; PIRSF001112; Epoxide_hydrolase; 1.
DR   PRINTS; PR00412; EPOXHYDRLASE.
DR   SUPFAM; SSF53474; alpha/beta-Hydrolases; 1.
PE   1: Evidence at protein level;
KW   Aromatic hydrocarbons catabolism; Detoxification;
KW   Direct protein sequencing; Endoplasmic reticulum; Hydrolase;
KW   Lipid metabolism; Membrane; Methylation; Microsome; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..455
FT                   /note="Epoxide hydrolase 1"
FT                   /id="PRO_0000080855"
FT   TRANSMEM        1..21
FT                   /note="Helical; Signal-anchor for type III membrane
FT                   protein"
FT                   /evidence="ECO:0000250|UniProtKB:P07687"
FT   TOPO_DOM        22..455
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P07687"
FT   ACT_SITE        226
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:P07687"
FT   ACT_SITE        374
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:P34913"
FT   ACT_SITE        431
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P07687"
FT   MOD_RES         295
FT                   /note="Dimethylated arginine"
FT                   /evidence="ECO:0000250|UniProtKB:P07687"
FT   VARIANT         43
FT                   /note="R -> T (in dbSNP:rs3738046)"
FT                   /evidence="ECO:0000269|Ref.8"
FT                   /id="VAR_023303"
FT   VARIANT         44
FT                   /note="E -> Q (in dbSNP:rs745306359)"
FT                   /evidence="ECO:0000269|PubMed:15618730"
FT                   /id="VAR_018347"
FT   VARIANT         49
FT                   /note="R -> C (in allele EPHX1*2; dbSNP:rs2234697)"
FT                   /evidence="ECO:0000269|PubMed:11058921"
FT                   /id="VAR_013298"
FT   VARIANT         113
FT                   /note="Y -> H (in allele EPHX1*3; benign variant; frequent
FT                   in the human population; 55% of wild type enzyme activity;
FT                   dbSNP:rs1051740)"
FT                   /evidence="ECO:0000269|PubMed:11058921,
FT                   ECO:0000269|PubMed:12173035, ECO:0000269|PubMed:15535985,
FT                   ECO:0000269|PubMed:7516776, ECO:0000269|Ref.8"
FT                   /id="VAR_005295"
FT   VARIANT         139
FT                   /note="H -> R (in allele EPHX1*4; benign variant; frequent
FT                   in the human population; 62% of wild type enzyme activity;
FT                   dbSNP:rs2234922)"
FT                   /evidence="ECO:0000269|PubMed:11058921,
FT                   ECO:0000269|PubMed:12173035, ECO:0000269|PubMed:15535985,
FT                   ECO:0000269|PubMed:7516776, ECO:0000269|Ref.8"
FT                   /id="VAR_005296"
FT   VARIANT         260
FT                   /note="L -> P (in allele EPHX1*1G)"
FT                   /evidence="ECO:0000269|PubMed:11058921"
FT                   /id="VAR_013299"
FT   VARIANT         275
FT                   /note="T -> A (in dbSNP:rs35073925)"
FT                   /id="VAR_051828"
FT   VARIANT         285
FT                   /note="V -> L (in dbSNP:rs45449793)"
FT                   /evidence="ECO:0000269|Ref.8"
FT                   /id="VAR_023304"
FT   VARIANT         396
FT                   /note="T -> I (either a rare variant or a sequencing
FT                   error)"
FT                   /evidence="ECO:0000269|PubMed:7516776"
FT                   /id="VAR_005297"
FT   VARIANT         408
FT                   /note="T -> M (in dbSNP:rs45495897)"
FT                   /evidence="ECO:0000269|Ref.8"
FT                   /id="VAR_023305"
FT   VARIANT         452
FT                   /note="L -> Q (in dbSNP:rs45563137)"
FT                   /evidence="ECO:0000269|Ref.8"
FT                   /id="VAR_023306"
FT   VARIANT         454
FT                   /note="R -> Q (in allele EPHX1*5; dbSNP:rs2234701)"
FT                   /evidence="ECO:0000269|PubMed:11058921"
FT                   /id="VAR_013300"
FT   CONFLICT        15
FT                   /note="I -> V (in Ref. 7; BAG36227)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        112
FT                   /note="R -> K (in Ref. 11)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        148
FT                   /note="H -> N (in Ref. 3 and 11)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        243
FT                   /note="V -> L (in Ref. 11)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        348
FT                   /note="K -> S (in Ref. 3; CAA68486)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        406
FT                   /note="L -> F (in Ref. 3; CAA68486)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        420
FT                   /note="L -> V (in Ref. 3; CAA68486)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   455 AA;  52949 MW;  88E333838C841390 CRC64;
     MWLEILLTSV LGFAIYWFIS RDKEETLPLE DGWWGPGTRS AAREDDSIRP FKVETSDEEI
     HDLHQRIDKF RFTPPLEDSC FHYGFNSNYL KKVISYWRNE FDWKKQVEIL NRYPHFKTKI
     EGLDIHFIHV KPPQLPAGHT PKPLLMVHGW PGSFYEFYKI IPLLTDPKNH GLSDEHVFEV
     ICPSIPGYGF SEASSKKGFN SVATARIFYK LMLRLGFQEF YIQGGDWGSL ICTNMAQLVP
     SHVKGLHLNM ALVLSNFSTL TLLLGQRFGR FLGLTERDVE LLYPVKEKVF YSLMRESGYM
     HIQCTKPDTV GSALNDSPVG LAAYILEKFS TWTNTEFRYL EDGGLERKFS LDDLLTNVML
     YWTTGTIISS QRFYKENLGQ GWMTQKHERM KVYVPTGFSA FPFELLHTPE KWVRFKYPKL
     ISYSYMVRGG HFAAFEEPEL LAQDIRKFLS VLERQ
//
